Cargando…
Polysomnographic and Clinical Parameters before and after Zonisamide Therapy for Parkinson's Disease
OBJECTIVE: Sleep disturbance is a common nonmotor symptom associated with a decreased quality of life in patients with Parkinson's disease (PD). In this study, we evaluated the effects of zonisamide on motor and non-motor symptomology in patients with PD, especially with respect to objective sl...
Autores principales: | Miyaue, Noriyuki, Yabe, Hayato |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017254/ https://www.ncbi.nlm.nih.gov/pubmed/35831101 http://dx.doi.org/10.2169/internalmedicine.0037-22 |
Ejemplares similares
-
Concomitant use of magnesium oxide significantly decreases absorption of levodopa preparations in patients with Parkinson’s disease
por: Miyaue, Noriyuki, et al.
Publicado: (2023) -
Serum GDF-15 Levels in Patients with Parkinson’s Disease, Progressive Supranuclear Palsy, and Multiple System Atrophy
por: Miyaue, Noriyuki, et al.
Publicado: (2023) -
Using Spontaneous Eye-blink Rates to Predict the Motor Status of Patients with Parkinson's Disease
por: Iwaki, Hirotaka, et al.
Publicado: (2019) -
Before–After Field Study of Effects of Wind Turbine Noise on Polysomnographic Sleep Parameters
por: Jalali, Leila, et al.
Publicado: (2016) -
Zonisamide effects on sleep problems and depressive symptoms in Parkinson’s disease
por: Suzuki, Keisuke, et al.
Publicado: (2021)